Success is best when the tumor is small; large cancers are surgically removed before the treatments and radiation is used to stop
further growth of any cells missed in the surgery.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain
growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize
cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant
further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Most
of the wireless industry is looking for new markets, as the number
of cell phones now
far exceeds the number
of people in the United States and revenue
growth is hard to find.
And it is the consensus
of experts that such tariffs themselves are
far from sufficient to result in widespread
growth in the domestic solar
cell and module manufacturing space.
Heretofore, this earth has witnessed the emergence
of single -
celled living organisms, the
growth of multicelled plant organisms, the advent
of animals with centralized nervous systems making self - directed activity possible, and the flowering
of humanity with its
far - flung culture.
In both cases individual members may exercise some dominance over others, in particular by altering the patterns guiding
further growth and development, but the social coordination stems from basic patterns embodied in the genetic makeup
of the plant
cells and in the laws and traditions
of human culture.
Lewis is now skimming through these genes to check their function;
of those he's looked at so
far, several are involved in
growth and development,
cell differentiation,
cell death, and protecting against cancer.
Lo's team set out to find ways to
further weaken the tumors, since the drug addiction response (which can range from a mere slow down
of the cancer's
growth rate to cancer
cell death), can be used to improve clinical outcomes.
«In most cases we think the body's
growth control mechanisms eventually stop the
cells from proliferating
further, but in occasional cases where additional mutations occur in the clump
of cells, a tumour will eventually develop,» says Andrew Wilkie also
of the University
of Oxford, who supervised the work.
Then came a new step: They carefully extracted the fragile, immature eggs and some surrounding
cells from the follicles, and allowed them to
further mature on a special membrane in the presence
of more
growth - supporting proteins.
Such a drug would block only the androgen receptor in prostate
cells, and so stop the chain
of reactions leading to
further tumour
growth, says McCague.
While
further research is needed to understand the effectiveness
of H1.0 protein in preventing the spread
of cancer
growth, this research advances significantly the study
of the mechanisms
of cancer stem
cells and the relatively new epigenetic approach to cancer research.
«You can see they are very active and affect the DNA in the tumor tremendously, causing lots
of mutations that may
further the
cells» uncontrolled
growth, says Alon Keinan, a computational biologist at Cornell University.
Further investigations could pave the way to a more complete understanding
of the genetics and metabolomics
of cell growth in yeast and the underlying mechanisms relevant to other settings in which
cells face challenging conditions, such as cancer progression and the evolution
of drug resistance.
Yet, more recent discoveries suggest a much more active role
of endothelial
cells during tumor
growth than has been anticipated so
far.
They have a burst
of growth that increases the pool
of cells waiting for the next mutation to push them even
further.
Ralph Brinster, part
of the team at the University
of Pennsylvania in Philadelphia that first cultured sperm stem
cells in the lab, has written that culturing stem
cells from human sperm is not
far off — humans and mice, like other mammals, he says, require similar
growth factors.
On the other hand, genetic mutations that
further promote the
growth of intestinal stem
cells are associated with uncontrolled organ regeneration and the development
of colon cancer.
We
further determined that T
cells deficient in DGKζ exhibit greater control
of murine pancreatic tumor
growth as compared with T
cells deficient in Cbl - b.
By stimulating the
growth of new blood vessels, promoting anti-inflammatory effects, recruiting
cells toward tissue regeneration and inhibiting
further cell death, adult stem
cells can restore some function to damaged or diseased heart muscle.
These abnormal
cells — in the case
of pulmonary hypertension, those that line the blood vessels leading to the lungs — release signals that stimulate the
growth of small new blood vessels to feed the renegade
cells, allowing
further proliferation, and thickening
of the vessel walls.
Six ovarian factors (BDNF, IGF - I, estradiol, GDNF, leptin and FGF2) were
further studied based upon the expression
of their receptors in oocytes and cumulus
cells described above, as well as the availability
of growth factor concentration information from previous animal model studies [1], [20], [21], [22], [23].
With each
cell division the telomeres
of most
cells shorten and this progressive DNA loss triggers a
growth arrest that prohibits the
cell from dividing
further.
«Our study also highlights that
growth of normal
cells and cancer
cells is driven by different gene switches, suggesting that
further work to find ways to control the activity
of such disease - specific switches could lead to novel, highly specific approaches for therapeutic intervention», says Professor Jussi Taipale, who led the study.
Further studies showed that Notch1 knockdown in NSCLC helps induce
cell death (which inhibits tumor initiation and
growth); this process is mediated by p53, and thus the effects
of inhibiting Notch1 require functional p53.
Further, white tea may be able to prevent the
growth of new fat
cells.
Cancer is said to be a disease
of old age, that is because we are living longer, we are encountering more carcinogens which
further mutate our DNA which can lead to uncontrolled
cell growth.
Pure pomegranate seed oil may help breast cancer patients inhibit
further growth of cancer
cells.
Start with a «fasting mimicking» diet, like our 26 - day detox, know that you're giving yourself an amazing health reboot — with some loss
of fat stores being an inevitable result, some increase in human
growth hormone and stem
cells — and congratulate yourself on your wins, as you think about taking it a step
further, potentially, later.
In summary, perhaps through glucose «starvation»
of tumour
cells and by reducing the effect
of direct insulin - related actions on
cell growth, ketogenic diets show promise as an aid in at least some kind
of cancer therapy and is deserving
of further and deeper investigation — certainly the evidence justifies setting up clinical trials.
Here's a quote: «Lactoferrin: Lactoferrin found in foods such as yogurt and kefir will stimulate new bone
growth while preventing
further breakdown
of existing bone tissue, lactoferrin enhances both the
growth and the activity
of osteoblasts (the
cells that build bone), and reduces the rate
of bone
cell death by 50 to 70 percent and decreases the development
of osteoclasts, the
cells responsible for breaking down bone.»
The exciting finding by University
of Washington researchers provides
further proof
of the powerful effect
of artemisinin on cancer and the powerful effect
of combining naturally - occurring herbals with other essentials, such as iron, to combat cancer
cell growth.
So
far this year, American Veterinarian ® has reported on immunotherapies that may slow
growth or even shrink gliomas in dogs and humans, a liquid biopsy assessment tool to detect tumor
cell mutation, and a shared study between the American Kennel Club Canine Health Foundation and the V Foundation for Cancer Research on the treatment
of bladder cancer.
Installations
of solar
cells are doubling every two years, and the annual
growth in wind generating capacity is not
far behind.
Sales
of solar
cells are doubling every two years, and the annual
growth in wind generating capacity is not
far behind.
He hates it so much that he
further compares its «monstrous
growth» to a hypertrophic, diseased organ that «grows to an abnormal size because
of the uncontrolled
growth of the
cells that constitute it.»